Open Beta
MetriLume

US marketsBTAIQ

SEC-sourced researchBeta

BTAIQ

BioXcel Therapeutics, Inc.

Company comparison ↗

Data passport

CIK
0001720893
Exchange
OTC
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Nov 17, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,266,000.0000 USD; December 2025: 642,000.0000 USD2.3M USD0 USD0December 2024December 2025
BTAIQ · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,266,000.0000Mar 27, 2026
December 2025642,000.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025642,000.0000-69,897,000.0000-57,615,000.000044,916,000.0000140,379,000.0000Mar 27, 2026
December 20242,266,000.0000-59,599,000.0000-72,027,000.000038,338,000.0000131,439,000.0000Mar 27, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

20/100
Profitability0
Growth0
Balance sheet0
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$642KJan 1, 2025 – Dec 31, 2025Mar 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.27MJan 1, 2024 – Dec 31, 2024Mar 27, 202610-K
Net incomeNetIncomeLoss-$69.9MJan 1, 2025 – Dec 31, 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$57.62MJan 1, 2025 – Dec 31, 2025Mar 27, 202610-K
Total assetsAssets$44.92MDec 31, 2025Mar 27, 202610-K
Total liabilitiesLiabilities$140.38MDec 31, 2025Mar 27, 202610-K

New filings

Explore methodology ↗